Toward the end of 2025, federal policy discussions placed renewed focus on maintaining strong workplace drug testing standards, especially in safety sensitive industries. This aligned with ongoing implementation of the HHS Mandatory Guidelines, which expanded federal drug testing panels to better reflect current substance trends and workplace safety needs.
By the time employers entered 2026, there was no sudden overhaul of testing rules. Instead, agencies continued reinforcing compliance with the existing federal framework already set by HHS and the Department of Transportation. In practical terms, companies that had already updated their testing panels and procedures after the HHS changes were simply expected to stay consistent and compliant, not start from scratch.
One of the most important updates from the HHS guidelines was the inclusion of fentanyl in federal workplace drug testing panels. This change was introduced to make testing more aligned with real world drug risks and to improve the accuracy of workplace screening programs. It did not change the purpose of testing, but it did make panels more current and relevant for today’s workforce.
Oral fluid testing also remained a key topic because it is now recognized under federal workplace drug testing guidelines as an approved specimen when conducted through certified laboratories and proper procedures. Currently this method has not yet been fully implemented as laboratories complete certification and federal programs finalize operational procedures.
Employers should focus on making sure their testing providers are using federally aligned drug panels, following approved collection methods, and maintaining proper documentation. Whether a company uses urine or oral fluid testing, the key requirement is that the program follows federal guidelines and uses certified processes.
The shift from late 2025 into 2026 is less about new rules and more about consistency. Federal guidance continues to support modernized drug testing panels, accurate detection of current substances, and compliant workplace testing programs that protect both employees and public safety while staying aligned with HHS Mandatory Guidelines and DOT drug and alcohol testing regulations.
If you have questions about how these updates apply to your workplace or you just want to make sure your program is set up correctly, MedPhysicals Plus is here to help. Give us a call at (907) 561-7587, email us at admin@medphysicalsplus.com, or visit medphysicalsplus.com to learn more about our services.
We proudly support employers across Anchorage, Fairbanks, Wasilla, or Soldotna, and we’re always ready to make compliance simpler and more manageable for your team.